Institutional profile: University of Florida Health Personalized Medicine Program

Author:

Cavallari Larisa H123,Weitzel Kristin W123,Elsey Amanda R13,Liu Xinyue4,Mosley Scott A12,Smith Donald M12,Staley Benjamin J45,Winterstein Almut G46,Mathews Carol A7,Franchi Francesco8,Rollini Fabiana8,Angiolillo Dominick J8,Starostik Petr9,Clare-Salzler Michael J39,Nelson David R210,Johnson Julie A12310

Affiliation:

1. Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA

2. Center for Pharmacogenomics, University of Florida, Gainesville, FL 32610, USA

3. Clinical & Translational Science Institute, University of Florida, Gainesville, FL 32610, USA

4. Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA

5. Department of Pharmacy, University of Florida Health Shands Hospital, Gainesville, FL 32608, USA

6. Department of Epidemiology, Colleges of Medicine & Public Health & Health Professions, University of Florida, Gainesville, FL 32610, USA

7. Department of Psychiatry, College of Medicine, University of Florida, Gainesville, FL 32610, USA

8. Department of Medicine, College of Medicine, University of Florida, Jacksonville, FL 32209, USA

9. Department of Pathology, Immunology & Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA

10. Department of Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA

Abstract

The University of Florida (UF) Health Personalized Medicine Program launched in 2012 with CYP2C19 genotyping for clopidogrel response at UF Health Shands Hospital. We have since expanded CYP2C19 genotyping to UF Health Jacksonville and established the infrastructure at UF Health to support clinical implementation for five additional gene–drug pairs: TPMT–thiopurines, IFNL3 (IL28B)–PEG IFN-α-based regimens, CYP2D6–opioids, CYP2D6/CYP2C19–antidepressants and CYP2C19–proton pump inhibitors. We are contributing to the evidence based on outcomes with genotype-guided therapy through pragmatic studies of our clinical implementations. In addition, we have developed a broad array of educational programs for providers, trainees and students that incorporate personal genotype evaluation to enhance participant learning.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3